Intolerance to 5-aminosalicylate is a risk of poor prognosis in ulcerative colitis patients

被引：0
|
作者：
Fujii, T. [1 ]
Hibiya, S. [1 ]
Maeyashiki, C. [2 ]
Saito, E. [1 ]
Takenaka, K. [1 ]
Motobayashi, M. [1 ]
Shimizu, H. [1 ]
Nagahori, M. [1 ]
Ohtsuka, K. [1 ]
Kurosaki, M. [2 ]
Yauchi, T. [3 ]
Watanabe, M. [1 ]
机构：
[1] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan
[2] Musashino Red Cross Hosp, Gastroenterol, Tokyo, Japan
[3] Soka Municipal Hosp, Gastroenterol, Soka, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P461
引用
收藏
页码：S409 / S410
页数：2
相关论文
共 50 条
  • [21] Efficacy of topical 5-aminosalicylate monotherapy in patients with ulcerative proctitis with skip inflammation
    Choi, Yong Sung
    Kim, Wan Jung
    Kim, Jong Kyu
    Kim, Do Sun
    Lee, Doo Han
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (06) : 1200 - 1206
  • [22] Distal ulcerative colitis refractory to oral/rectal steroids and granulocytapheresis promptly responded to 5-aminosalicylate enemas
    Ueno, F
    Itoh, T
    Ide, H
    Takatsuka, K
    Iwabuchi, S
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S175 - S175
  • [23] MAINTENANCE THERAPY WITH LOWER DOSE 5-AMINOSALICYLATE INCREASES THE CLINICAL RELAPSE IN PATIENTS WITH ULCERATIVE COLITIS WHO HAD PREVIOUS USE OF CORTICOSTEROIDS
    Fukuda, Tomohiro
    Naganuma, Makoto
    Sugimoto, Shinya
    Nanki, Kosaku
    Mizuno, Shinta
    Nakazato, Yoshihiro
    Ogata, Haruhiko
    Iwao, Yasushi
    Kanai, Takanori
    GASTROENTEROLOGY, 2017, 152 (05) : S409 - S409
  • [24] MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis
    Hu, Mary Y.
    Peppercorn, Mark A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (06) : 1049 - 1058
  • [25] TREATMENT OF CHRONIC ULCERATIVE-COLITIS WITH POLY-ASA - A NEW NONABSORBABLE CARRIER FOR RELEASE OF 5-AMINOSALICYLATE IN THE COLON
    GARRETTO, M
    RIDDELL, RH
    WINANS, CS
    GASTROENTEROLOGY, 1983, 84 (05) : 1162 - 1162
  • [26] THE IMPACT OF BIOLOGICS WITH OR WITHOUT 5-AMINOSALICYLATE ACID ON CLINICAL OUTCOMES OF ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Shi, Lu Bo
    Zhou, Anni
    Dang, Yan
    Zhang, Shutian
    Shi, Hai Yun
    GASTROENTEROLOGY, 2023, 164 (06) : S301 - S302
  • [27] DOUBLE-BLIND COMPARISON OF SLOW-RELEASE 5-AMINOSALICYLATE AND SULFASALAZINE IN REMISSION MAINTENANCE IN ULCERATIVE-COLITIS
    MULDER, CJJ
    TYTGAT, GNJ
    WETERMAN, IT
    DEKKER, W
    BLOK, P
    SCHRIJVER, M
    VANDERHEIDE, H
    GASTROENTEROLOGY, 1988, 95 (06) : 1449 - 1453
  • [28] Does the 5-Aminosalicylate Concentration Correlate with the Efficacy of Oral 5-Aminosalicylate and Predict Response in Patients with Inflammatory Bowel Disease? A Systematic Review
    van de Meeberg, Maartje M.
    Schultheiss, Johannes P. D.
    Oldenburg, Bas
    Fidder, Herma H.
    Huitema, Alwin D. R.
    DIGESTION, 2020, 101 (03) : 245 - 261
  • [29] Classification and clinical features of adverse drug reactions in patients with ulcerative colitis treated with 5-aminosalicylate acid: a single-center, observational study
    Tsujii, Yuri
    Nishida, Tsutomu
    Osugi, Naoto
    Fujii, Yoshifumi
    Sugimoto, Aya
    Nakamatsu, Dai
    Mukai, Kaori
    Matsumoto, Kengo
    Hayashi, Shiro
    Yamamoto, Masashi
    Nakajima, Sachiko
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (02) : 190 - 196
  • [30] Long-Term Clinical Outcomes and Factors Predictive of Relapse after 5-Aminosalicylate or Sulfasalazine Therapy in Patients with Mild-to-Moderate Ulcerative Colitis
    Lee, Hyun Jung
    Jung, Eun Suk
    Lee, Jin Ha
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    HEPATO-GASTROENTEROLOGY, 2012, 59 (117) : 1415 - 1420
12345